metastatic breast cancer (mbc)
Showing 1 - 6 of 6
Metastatic Breast Cancer (MBC) Trial in Nanjing, Shanghai (Paclitaxel Polymeric Micelles for Injection, Eribulin Mesilate
Recruiting
- Metastatic Breast Cancer (MBC)
- Paclitaxel Polymeric Micelles for Injection
- +5 more
-
Nanjing, Jiangsu, China
- +2 more
Nov 21, 2023
Metastatic Breast Cancer (MBC) Trial in United States (Palbociclib, Bicalutamide)
Active, not recruiting
- Metastatic Breast Cancer (MBC)
-
Basking Ridge, New Jersey
- +4 more
Oct 31, 2022
Locally Advance Breast Cancer (LABC), Metastatic Breast Cancer (MBC) Trial in Madrid, Leicester, Manchester (BEZ235 +
Completed
- Locally Advance Breast Cancer (LABC)
- Metastatic Breast Cancer (MBC)
- BEZ235 + Trastuzumab Phase l/Phase ll)
- Lapatinib + Capecitabine (Phase II)
-
Madrid, Spain
- +2 more
Dec 6, 2020
Inoperable Locally Advanced Breast Cancer, Metastatic Breast Cancer (MBC) Trial in Dijon Cedex, Saint-Herblain Cédex, Hospitalet
Terminated
- Inoperable Locally Advanced Breast Cancer
- Metastatic Breast Cancer (MBC)
-
Dijon Cedex, France
- +2 more
Dec 6, 2020
Stage IV NSCLC (NSCLC), Recurrent NSCLC (NSCLC), Extensive-stage Small Cell Lung Cancer (SCLC) Trial in Stanford (Pegylated
Completed
- Stage IV Non-small Cell Lung Cancer (NSCLC)
- +5 more
- Pegylated Irinotecan
-
Stanford, CaliforniaStanford University, School of Medicine
Nov 4, 2019
